Intesa and Innogest-backed Silicon Biosystems forms US subsidiary

Silicon Biosystems plans for the new entity, Silicon Biosystems Inc, to concentrate on the development of the US research and clinical diagnostics markets for its DEPArray technology platform. It will be based in San Diego, California.

Innogest invested £3.7m in the parent company in July 2007. In March 2010 it then co-led a £5m funding round alongside Atlante Ventures, the venture capital fund of the Intesa Sanpaolo Group, which committed €2m. Business angels also subscribed to the round.

Company
Silicon Biosystems is a Bologna-based provider of specialised molecular and cell biotechnology. It was founded in 1999 and employs 30 people.

People
Aurelio Mezzotero is the investment director at Atlante, while Claudio Giuliano and Marco Pinciroli are the managing partners of Innogest.

Giuseppe Giorgini is the CEO of Silicon Biosystems.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Southern Europe
• Technology
• Expansion
• Portfolio management
• Banca Intesa